Celestra Inc. (KOSDAQ: A352770)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
Celestra Inc. (KOSDAQ: A352770) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.28M.
trading between 4.24K and 33.97K.
Tweenvest scores Celestra Inc. across four factors: quality 15/100. Its strongest factor is quality.
A352770 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.28M
- Revenue (TTM)
- $963.20K
- P/E
- —
- EPS
- -670.32
- Dividend yield
- —
- Beta (5Y)
- 0.83
- 52-week high
- ₩33,975.00
- 52-week low
- ₩4,245.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.56M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $266.47 | +0.74% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $444.00 | +0.04% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.11 | +0.93% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $554.56 | +1.27% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $835.68 | +0.87% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $159.02 | +14.49% |
Figures last refreshed Aug 18, 2026.